Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. (Q51372135)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 July 2005

Language	Label	Description	Also known as
English	Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.	scientific article published on 27 July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

0 references

systemic immune response

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Monika Manocha

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Pramod Chandra Pal

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

K T Chitralekha

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Beena Elizabeth Thomas

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Vinita Tripathi

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Siddhartha Dutta Gupta

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Ramesh Paranjape

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Smita Kulkarni

8

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

D Nageswara Rao

9

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

language of work or name

0 references

publication date

27 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

23

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

48-49

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

5599-5617

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

The Role of Mucosal Immunity in Prevention of HIV Transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Detection of IgA inhibiting the interaction between gp120 and soluble CD4 receptor in serum and saliva of HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches--a personal and historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Antigenic analysis of HIV type 1 external envelope (Env) glycoprotein C2 region: implication for the structure of Env.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Inducing a cell-mediated immune response against peptides of the Plasmodium vivax circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Murine Peyer's patch T cell clones. Characterization of antigen-specific helper T cells for immunoglobulin A responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Effects of Parenteral and Enteral Nutrition on Gut-Associated Lymphoid Tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Bioactive fragment of human IL-1beta [163-171] modulates the immune response to synthetic peptides of HIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intrinsic and extrinsic factors in protein antigenic structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Structural requirements for synthetic immunogens to induce measles virus specific CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.06.031

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51372135&oldid=1589575713"